Live Webinar on The Investigator Agreement: How and When to Complete FDA Form 1572 By Compliance2go

8 January 2012, Houston, Texas, United States

If you read FDA warning letters (and you should!), you are aware that the number of citations for failure to correctly complete the required FDA Form 1572 are increasing. An FDA Form 1572 is required for drug or biologic studies conducted under an IND, whether in the U.S. or abroad. Similarly, medical device trials require a signed agreement from each investigator that contains information similar to that requested in the 1572.

There has been long standing confusion and disagreement over who should be listed as a sub-investigator on the 1572. Even experienced clinical investigators continue to struggle with 1572 completion questions and this challenge is further complicated by the growing complexity of clinical trials, which may involve multiple 'satellite sites' or distributing other study functions.

Compliance2go, 10777 Westheimer Suite 1100, Houston, Texas, 77042, United States

Organised by
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry